GovChime
IDVSmall business

IDC (multiple-award IDV) HHSN272201700028ISIGMOVIR BIOSYSTEMS, INC.

Overview

Award facts

Obligated on orders under this IDV
$4.17M
$4,172,423 across 3 orders
Period of performance
From Jul 13, 2017
Modifications
2
Latest action Oct 14, 2021
Contract type
IDC (multiple-award IDV)
PIID HHSN272201700028I

Description of requirement

IGF::OT::IGF PRE-CLINICAL MODELS OF INFECTIOUS DISEASES

Dates and value

Award date
Signed on Jul 13, 2017
Ordering period ends
Jul 13, 2024
Ceiling
Shared program ceiling (all awardees of this multiple-award vehicle, not a per-awardee value): $40,000,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Oct 14, 2021. View on USAspending · Recipient on SAM.gov

Recipient

NameSIGMOVIR BIOSYSTEMS, INC.
LocationROCKVILLE, MD
UEIUJEMT86834H8
CAGE code668Z1
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companySIGMOVIR BIOSYSTEMS, INC.

Business types and certifications

For-profit organizationSubchapter S corporationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID

Classification and competition

Classification

NAICS
541711RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Product or service (PSC)
AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Order dependent (IDV allows pricing arrangement to be determined separately for each order)1
Offers received
67

Solicitation and notices

Solicitation ID
NIHAI2016059(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Major program
Pre-clinical models of infectious diseases
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Jul 13, 2017
Latest action
Oct 14, 2021 — Other administrative actionModification P00002; administrative: no change in scope or value
Actions by type
  • Base award1
  • Other administrative action2
3 actions recorded, Jul 13, 2017 to Oct 14, 2021; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA

Structure

Award or IDV
IDV
IDV type
IDCB
Indefinite-delivery contract type
Indefinite delivery / indefinite quantityB
Multiple or single award
Multiple awardM
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
3

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930